Lung lesions and anti-ulcer agents beneficial effect: Anti-ulcer agents pentadecapeptide BPC 157, ranitidine, omeprazole and atropine ameliorate lung lesion in rats

Journal of Physiology-Paris - Tập 95 - Trang 303-308 - 2001
Dinko Stancic-Rokotov1, Zoran Slobodnjak1, Josip Aralica2,3, Gorana Aralica2,3, Darko Perovic2,3, Mario Staresinic2,3, Miroslav Gjurasin2,3, Tomislav Anic2,3, Ivan Zoricic2,3, Gojko Buljat2,3, Ingrid Prkacin2,3, Predrag Sikiric2,3, Sven Seiwerth2,3, Rudolf Rucman2,3, Marijan Petek2,3, Branko Turkovic2,3, Neven Kokic2,3, Vjekoslav Jagic2,3, Alenka Boban-Blagaic2,3
1Clinic for Thoracic Surgery Jordanovac, Medical Faculty University of Zagreb, Zagreb, Croatia
2Department of Pharmacology, Medical Faculty University of Zagreb, Salata 11, PO Box 916, 10000 Zagreb, Croatia
3Department of Pathology, Medical Faculty University of Zagreb, Salata 11, PO Box 936, 10000 Zagreb, Croatia

Tài liệu tham khảo

Allibone, 1958, Bronchitis, aspirin, smoking, and other factors in the aetiology of peptic ulcer, Lancet, 7, 179, 10.1016/S0140-6736(58)91526-5 Clissold, 1986, Omeprazole, An updated review, Drugs, 32, 15, 10.2165/00003495-198632010-00002 Cobb, 1965, Newly identified clusters of diseases, rheumatoid arthritis, peptic ulcer, and tuberculosis, JAMA, 193, 1077, 10.1001/jama.1965.03090130005001 Cook, 1998, A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation, Canadian Critical Care Trials Group, N. Eng. J. Med., 338, 791, 10.1056/NEJM199803193381203 Cook, 1996, Stress ulcer prophylaxis in critically ill patients, Resolving discordant meta-analyses, JAMA, 275, 308, 10.1001/jama.1996.03530280060038 Dawson-Saunders, 1994 Jelovac, 1999, Buljat G, Prkacin I, Pentadecapeptide BPC 157 attenuates disturbances induced by neuroleptics: The effect on catalepsy and gastric ulcers. European J. Pharmacol., 379, 19 Koblik, 1994, The lung, 673 Kramer, 1960, Gastric acid secretion in chronic obstructive pulmonary emphysema, Gastroenterology, 38, 296, 10.1016/S0016-5085(60)80131-X Lee, 1998, Neither dopamine nor dobutamine corrects mesenteric blood flow depression caused by positive end-expiratory pressure in a rat model of acute lung injury, Crit. Care Med., 26, 1875, 10.1097/00003246-199811000-00032 Mikus, 2001, Pentadecapeptide BPC 157 cream improves burn-wound healing and attenuates burn-gastric lesions in mice, Burns, 10.1016/S0305-4179(01)00055-9 Moron, 1984, Comparative study of the cytoprotective effects of anticholinergic agents on the gastric mucosal lesions produced by intragastric administration of 0.6 M HCl in rats, 61 O'Keefe, 1998, Incidence of infectious complications associated with the use of histamine2-receptor antagonists in critically ill trauma patients, Ann. Surg., 227, 120, 10.1097/00000658-199801000-00017 Palitzsch, 1995, Lung damage aggravates gastric mucosal lesions induced by ethanol in the rats, Digestion, 56, 204, 10.1159/000201244 Radomski, 1998, The role of nitric oxide and metalloproteinases in the pathogenesis of hyperoxia-induced lung injury in newborn rats, Br. J. Pharmacol., 125, 1455, 10.1038/sj.bjp.0702216 Robert, 1979, Cytoprotection by prostaglandins, Gastroenterology, 77, 761, 10.1016/0016-5085(79)90235-X Sikiric, 1999, Long-lasting cytoprotection after pentadecapeptide BPC 157, ranitidine, sucralfate or cholestyramine application in reflux oesophagitis in rats, J. Physiol. (Paris), 93, 467, 10.1016/S0928-4257(99)00124-2 Sikiric, 1997, Pentadecapeptide BPC 157, cimetidine, ranitidine, bromocriptine and atropine effect in cysteamine lesions in totally gastrectomized rats A model study for cytoprotective studies, Dig. Dis. Sci., 42, 1029, 10.1023/A:1018893220943 Sikiric, 1993, A new gastric juice peptide BPC- an overview of stomach/stress/organoprotection hypothesis and BPC beneficial effects, J. Physiol. (Paris), 87, 313, 10.1016/0928-4257(93)90038-U Sikiric, 1999, New model of cytoprotection/adaptive cytoprotection in rats, European J. Pharmacol., 364, 23, 10.1016/S0014-2999(98)00818-8 Sikiric, 1994, The beneficial effect of BPC 157, a 15 aminoacid peptide BPC fragment, on gastric and duodenal lesions induced by restraint stress, cysteamine and 96% ethanol in rats, A comparative study with H2 receptor antagonists, dopamine promotors and gut peptides, Life Sci., 54, 63, 10.1016/0024-3205(94)00796-9 Sikiric, 1996, The beneficial effect of a novel pentadecapeptide BPC 157 on gastric lesions induced by restraint stress, ethanol, indomethacin and capsaicin neurotoxicity, Dig. Dis. Sci., 41, 1604, 10.1007/BF02087908 Sikiric, 1997, Pentadecapeptide BPC 157 positively affects both non-steroidal anti-inlammatory agents-induced gastrointestinal lesions and adjuvant arthritis in rats, J. Physiol. (Paris), 91, 113, 10.1016/S0928-4257(97)89474-0 Sikiric, 1997, The influence of a novel pentadecapeptide, BPC 157, on N(G)-nitro-L-arginine methylester and L-arginine effects on stomach mucosa integrity and blood pressure, European J. Pharmacol., 332, 23, 10.1016/S0014-2999(97)01033-9 Sikiric, 1998, Lesions induced in colon and duodenum by cysteamine, Gastroenterology, 114, 1085, 10.1016/S0016-5085(98)84412-0 Tsukahara, 1999, Phospholipase A2 mediates nitric oxide production by alveolar macrophages and acute lung injury in pancreatitis, Ann. Surg., 229, 385, 10.1097/00000658-199903000-00012 Veljaca, 1995, Digestion of h-EGF, h-TGF alpha, and BPC-15 in human gastric juice, Gastroenterology, 108, 761, 10.1016/0016-5085(95)27355-7 Veljaca, 1994, BPC-15 reduces trinitrobenzene sulfonic acid-induced colonic damage in rats, J. Pharmacol. Exp. Ther., 272, 417422 Veljaca, 1995, Protection of BPC-15 on TNBS-induced colitis in rats, Gastroenterology, 108, 936, 10.1016/0016-5085(95)28049-9